Compounds > indium tris(tropolonate)
Page last updated: 2024-09-03

indium tris(tropolonate) and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

indium tris(tropolonate) has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Compound Research Comparison

Studies
(indium tris(tropolonate))		Trials
(indium tris(tropolonate))		Recent Studies (post-2010)
(indium tris(tropolonate))		Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
64209,156187552

Protein Interaction Comparison

ProteinTaxonomyindium tris(tropolonate) (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clague, J; Dixon, CM; Henderson, BL; Ind, PW; Lavender, JP; Peters, AM; Stuttle, AW; Tam, FW1

Other Studies

1 other study(ies) available for indium tris(tropolonate) and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Inhaled platelet-activating factor causes pulmonary neutrophil sequestration in normal humans.
    The American review of respiratory disease, 1992, Volume: 146, Issue:4

    Topics: Administration, Inhalation; Adult; Blood Platelets; Bronchial Provocation Tests; Erythrocytes; Humans; Indium Radioisotopes; Lung; Male; Neutrophils; Organometallic Compounds; Platelet Activating Factor; Platelet Count; Radionuclide Imaging; Technetium; Time Factors; Tropolone

1992